Zika Virus Vaccines

The Live-Attenuated vaccine is produced to the disease caused by Zika Virus. The monovalent form of the antibody is outlined against Zika infection contamination. Zika Virus has a place with the Genus Flavivirus, or, in other words the Aedes mosquitos. The comprehension of flavivirus molecule structure, meaning of E dimers as the key antigenic target, and profound comprehension of balance systems help to build up the antibody.

  • Zika Virus Vaccines Clinical Trials
  • Zika Virus Vaccine Development
  • Zika Virus Vaccines Recent Research
  • Zika Virus Vaccines Recent Research
  • Purified Inactivated Vaccine

Related Conference of Zika Virus Vaccines

October 12-13, 2020

11th World Climate Change Conference

Valencia, Spain
October 12-13, 2020

9th World Conference on Climate Change

Zurich, Switzerland
October 19-20, 2020

9th International Conference on Environmental Chemistry

Athens, Greece
October 26-27-2020

4th World Congress on Environmental Toxicology

Osaka, Japan
November 09-10, 2020

17th World Congress and Expo on Recycling

Amsterdam, Netherlands
November 18-19, 2020

7th Global summit on Climate Change

Lisbon, Portugal
November 18-19, 2020

36th World Vaccines & Immunization Congress

| Bangkok, Thailand
November 23-24, 2020

6th International Conference on GIS and Remote Sensing

Barcelona, Spain
November 23-24, 2020

15th International Conference on Biofuels and Bioenergy

Edinburgh, Scotland
December 10-11, 2020

4th World Summit on Renewable Energy and Resources

Dubai, UAE
December 10-11, 2020

Global Congress on Sustainable Energy and Fuels

Dubai, UAE
February 15-16, 2021

14th International Conference on Biofuels and Bioenergy

Paris, France

Zika Virus Vaccines Conference Speakers

Recommended Sessions

Related Journals

Are you interested in